$5.390
-0.320 (-5.93%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
KYTX Prediction & Forecast by Similar Chart Analysis
Alphio's KYTX stock price prediction model matches the current Kyverna Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.43 (+0.72%). The 1-week path is $5.36 (-0.54%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Kyverna Therapeutics Inc Stock?
Kyverna Therapeutics Inc is not a good buy right now due to its current price of $5.67, which is significantly below the analyst price targets of $25 and $29. However, the stock has seen a 35.35% decline year-to-date, indicating potential for recovery. The RSI is at 29.778, suggesting the stock is oversold, but the negative earnings trend with a forward P/E of 0 and consistent losses (latest EPS reported at -0.63) raises concerns about its financial health. The main risk is the ongoing net losses, with a net income of -39,728,000 USD in Q1 2026, which could hinder future growth and recovery.
KYTX stock price ended at $5.39 on Friday, after losing -5.93%
Kyverna Therapeutics Inc (KYTX) last closed at $5.39, losing -5.93%. These facts feed the 1-day and 1-week KYTX price prediction above.
Forecast Drivers
Kyverna Therapeutics Inc (KYTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches KYTX, ranked by similarity.
Seasonality analysis for KYTX
Historically the probability of a positive October return for KYTX is 36.51%. December offers the highest probability of a positive month at 51.16%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for KYTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $3.24 | $3.80 | $4.02 | -29.54% |
| Nov 2026 | $3.51 | $4.26 | $4.92 | -20.92% |
| Dec 2026 | $3.43 | $3.52 | $4.24 | -34.76% |
In 2026, Kyverna Therapeutics Inc (KYTX) is projected to range from $3.24 to $4.92.
Kyverna Therapeutics Inc 2026 monthly forecast
In Oct 2026, Kyverna Therapeutics Inc is projected to average $3.80, with a low of $3.24 and high of $4.02.
In Nov 2026, Kyverna Therapeutics Inc is projected to average $4.26, with a low of $3.51 and high of $4.92.
In Dec 2026, Kyverna Therapeutics Inc is projected to average $3.52, with a low of $3.43 and high of $4.24.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.